Le Lézard
Classified in: Science and technology
Subject: Award

Epicor Celebrates Partner Success with 2024 International Partner Excellence Awards


Epicor, a global leader of industry-specific enterprise software to promote business growth, celebrated the winners of its International Partner Excellence Awards at the company's annual Momentum Partner Conference, held in Bangkok, Thailand last week.

The awards showcase International Channel Partner successes, recognising those that have excelled in enhancing the value they deliver to customers and their commitment to the growth of Epicor business.

"Epicor Channel Partners across our regions are elevating the customer experience and helping organizations across the make, move, and sell economy navigate their digital transformation journeys to drive growth and success," said Paul Flannery, Epicor Vice President, International Channel Sales. "We are thrilled to recognise some of these standout partners and the innovative work they've done to deliver for our shared customers."

This year's award winners included:

Andy Coussins, Epicor Executive Vice President, International concluded, "We had a very strong set of nominations, and a common theme throughout was how our International Channel Partners are looking to deliver the best possible customer experience and business outcomes for their customers. Congratulations to all our worthy winners ? their strong collaborations mean that we are able to continue to support our customers across the make, move, and sell industries."

For more information on the Epicor Partner Community please visit our website.

About Epicor

Epicor equips hard-working businesses with enterprise solutions that keep the world turning. For 50 years, Epicor customers in the automotive, building supply, distribution, manufacturing, and retail industries have trusted Epicor to help them do business better. Innovative Epicor solution sets are carefully curated to fit customer needs and built to flexibly respond to their fast-changing reality. With deep industry knowledge and experience, Epicor accelerates its customers' ambitions, whether to grow and transform, or simply become more productive and effective. Visit www.epicor.com for more information.

Epicor and the Epicor logo are trademarks of Epicor Software Corporation, registered in the United States and other countries. Other trademarks referenced are the property of their respective owners. The product and service offerings depicted in this document are produced by Epicor Software Corporation. Results are not guaranteed, and each user's experience will vary.


These press releases may also interest you

at 06:02
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major...

at 06:00
Amplify10, the trailblazer in SaaS AI-Powered Sales Execution solutions, proudly announces its official launch today, aimed at reshaping the landscape of sales performance for enterprises worldwide. The early-stage company, formerly known as...

at 06:00
Quhuo Limited ("Quhuo" or the "Company") , a leading gig economy platform focusing on local life services in China, today announced that Ms. Chenxi Zhao has resigned from her position as a member of the board of directors (the "Board"), effective on...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:45
A report from China.org.cn:  China Duty Free Group (CDFG), the world's leading travel retail operator, outlined its strategy for continued growth at the recently concluded TFWA Asia Pacific Exhibition & Conference held in Singapore from May 12 to...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...



News published on and distributed by: